BMSCs were shown to induce bortezomib-resistant NFκB activity in MM cells which was mediated by soluble factors including IL-8 from BMSCs [216], providing a supportive explanation to bortezomib resistance in a large number of MM patients [137]. Here, NFKB1 is linked to Miyoshi myopathy.